Katarzyna A Gajewska1, Regien Biesma2, Kathleen Bennett3, Seamus Sreenan4,5. 1. Division of Population Health Sciences, RCSI: University of Medicine and Health Sciences, Beaux Lane House, Mercer Street Lower, Dublin 2, Dublin, Ireland. katarzynagajewska@rcsi.ie. 2. Global Health Unit, Department of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands. 3. Division of Population Health Sciences, RCSI: University of Medicine and Health Sciences, Beaux Lane House, Mercer Street Lower, Dublin 2, Dublin, Ireland. 4. 3U Diabetes, RCSI: University of Medicine and Health Sciences, Dublin, Ireland. 5. Department of Diabetes and Endocrinology, RCSI: University of Medicine and Health Sciences, Connolly Hospital, Dublin, Ireland.
Abstract
AIMS: Uptake of continuous subcutaneous insulin infusion (CSII) by people with diabetes (PwD) in Ireland is low and exhibits regional variation. This study explores barriers and facilitators to accessing CSII by adults with Type 1 diabetes mellitus. RESEARCH DESIGN AND METHODS: A qualitative study employing focus groups with adults with Type 1 diabetes mellitus (n = 26) and semi-structured interviews with health care professionals (HCP) and other key stakeholders (n = 21) was conducted. Reflexive thematic analysis was used to analyze data, using NVivo. RESULTS: Four main themes comprising barriers to or facilitators of CSII uptake were identified. These included: (1) awareness of CSII and its benefits, (2) the structure of diabetes services, (3) the capacity of the diabetes service to deliver the CSII service, and (4) the impact of individuals' attitudes and personal characteristics-both PwD, and HCP. Each of these themes was associated with a number of categories, of which 18 were identified and explored. If the structure of the health-service is insufficient and capacity is poor (e.g., under-resourced clinics), CSII uptake appears to be impacted by individuals': interest, attitude, willingness and motivation, which may intensify the regional inequality in accessing CSII. CONCLUSIONS: This study identified factors that contribute to gaps in the delivery of diabetes care that policy-makers may use to improve access to CSII for adult PwD.
AIMS: Uptake of continuous subcutaneous insulin infusion (CSII) by people with diabetes (PwD) in Ireland is low and exhibits regional variation. This study explores barriers and facilitators to accessing CSII by adults with Type 1 diabetes mellitus. RESEARCH DESIGN AND METHODS: A qualitative study employing focus groups with adults with Type 1 diabetes mellitus (n = 26) and semi-structured interviews with health care professionals (HCP) and other key stakeholders (n = 21) was conducted. Reflexive thematic analysis was used to analyze data, using NVivo. RESULTS: Four main themes comprising barriers to or facilitators of CSII uptake were identified. These included: (1) awareness of CSII and its benefits, (2) the structure of diabetes services, (3) the capacity of the diabetes service to deliver the CSII service, and (4) the impact of individuals' attitudes and personal characteristics-both PwD, and HCP. Each of these themes was associated with a number of categories, of which 18 were identified and explored. If the structure of the health-service is insufficient and capacity is poor (e.g., under-resourced clinics), CSII uptake appears to be impacted by individuals': interest, attitude, willingness and motivation, which may intensify the regional inequality in accessing CSII. CONCLUSIONS: This study identified factors that contribute to gaps in the delivery of diabetes care that policy-makers may use to improve access to CSII for adult PwD.
Entities:
Keywords:
Continuous subcutaneous insulin infusion; Diabetes technology; Health-services research; Insulin pumps; Medical device; Qualitative research; Type 1 diabetes
Authors: H D White; N Goenka; N J Furlong; S Saunders; G Morrison; P Langridge; P Paul; A Ghatak; P J Weston Journal: Diabet Med Date: 2013-11-08 Impact factor: 4.359
Authors: Jennifer L Sherr; Martin Tauschmann; Tadej Battelino; Martin de Bock; Gregory Forlenza; Rossana Roman; Korey K Hood; David M Maahs Journal: Pediatr Diabetes Date: 2018-10 Impact factor: 4.866
Authors: N Waugh; P Royle; C Clar; R Henderson; E Cummins; D Hadden; R Lindsay; D Pearson Journal: Health Technol Assess Date: 2010-09 Impact factor: 4.014
Authors: J A McKnight; S H Wild; M J E Lamb; M N Cooper; T W Jones; E A Davis; S Hofer; M Fritsch; E Schober; J Svensson; T Almdal; R Young; J T Warner; B Delemer; P F Souchon; R W Holl; W Karges; D M Kieninger; S Tigas; A Bargiota; C Sampanis; V Cherubini; R Gesuita; I Strele; S Pildava; K J Coppell; G Magee; J G Cooper; S F Dinneen; K Eeg-Olofsson; A-M Svensson; S Gudbjornsdottir; H Veeze; H-J Aanstoot; M Khalangot; W V Tamborlane; K M Miller Journal: Diabet Med Date: 2015-02-21 Impact factor: 4.359
Authors: Lawrence A Palinkas; Sarah M Horwitz; Carla A Green; Jennifer P Wisdom; Naihua Duan; Kimberly Hoagwood Journal: Adm Policy Ment Health Date: 2015-09
Authors: Kevin T Nguyen; Nicole Y Xu; Bruce A Buckingham; Sarnath Chattaraj; Ohad Cohen; Lutz Heinemann; John Pickup; Jannet Svensson; Robert A Vigersky; Jenise C Wong; Ralph Ziegler Journal: J Diabetes Sci Technol Date: 2022-02-28
Authors: Ananta Addala; Sakinah C Suttiratana; Jessie J Wong; Monica S Lanning; Katharine D Barnard; Jill Weissberg-Benchell; Lori M Laffel; Korey K Hood; Diana Naranjo Journal: Diabet Med Date: 2021-04-13 Impact factor: 4.213